The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 11,500.00
Ask: 12,200.00
Change: 0.00 (0.00%)
Spread: 700.00 (6.087%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 100 movers: BP boosted by lower-than-expected fine, ARM hit by Intel competition

Fri, 16th Jan 2015 12:53

Oil giant BP was among the risers after the company revealed it faces a maximum penalty of $13.7bn under the Clean Water Act. This follows the District Court for the Eastern District of Louisiana ruling on the Deepwater Horizon case, which found that 3.19m barrels of oil were discharged in the Gulf of Mexico in 2010. The bill, which was some $4bn less than feared, put the spill's size below the government's 4.09m estimate and just under the 3.26m estimated by the firm. Sector peer BHP Billiton was also up, after oil prices advanced on Friday morning. Brent futures were up 2.6% at $49.50 a barrel after the International Energy Agency (IEA) said a turnaround could be on the horizon. "A price recovery - barring any major disruption - may not be imminent, but signs are mounting that the tide will turn. A rebalancing may begin to occur in the second half of the year," the IEA said, as it lowered its forecasts for non-OPEC supply.Imperial Tobacco's share prices were boosted as Morgan Stanley hiked its target price from 2,680p to 3,250p and named the stock its new top pick, saying it is "increasingly optimistic" about its pending $7bn acquisition of assets from Reynolds and Lorillard.BT Group shares were also higher after being upgraded from 'hold' to 'buy' by Societe Generale.Meanwhile ARM Holdings took a hit after US chip rival Intel revealed it had sold more-than-expected chips for tablets in 2014 on Thursday night. Liberum kept a 'sell' rating on ARM, saying that competition from Intel is now rising in the smartphone sector, "which could take share from ARM in its core market".AstraZeneca was falling following a downgrade from Barclays Capital from 'equal weight' to 'underweight'. The broker said: "In an interview with The Times late last year CEO Pascal Soriot urged investors to not fixate on the Long-Range Plan central to its bid defence against Pfizer and to focus instead on margins. We view this as a tacit admission that management's $45 bn 2023 revenue projection is unrealistic and we view 2017 revenue guidance as equally unlikely to be met." RisersExperian (EXPN) 1,162.00p +3.66%Antofagasta (ANTO) 688.50p +2.76%BP (BP.) 403.40p +2.75%Glencore (GLEN) 247.05p +2.68%Anglo American (AAL) 1,087.00p +2.60%BG Group (BG.) 836.90p +2.01%BT Group (BT.A) 407.80p +1.90%BHP Billiton (BLT) 1,373.50p +1.89%Imperial Tobacco Group (IMT) 2,904.00p +1.89%Standard Life (SL.) 392.20p +1.24% FallerseasyJet (EZJ) 1,600.00p -2.74%Wolseley (WOS) 3,601.00p -2.54%Mondi (MNDI) 1,052.00p -2.41%Dixons Carphone (DC.) 424.30p -2.33%ARM Holdings (ARM) 974.00p -2.16%Babcock International Group (BAB) 1,003.00p -1.57%AstraZeneca (AZN) 4,661.50p -1.43%Burberry Group (BRBY) 1,661.00p -1.37%Persimmon (PSN) 1,436.00p -1.37%Meggitt (MGGT) 511.00p -1.35%
More News
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.